Health Canada has reminded hospitals that Anzemet [dolasetron] is contraindicated in patients aged

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1109, 2006-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Health Canada has published a notice to hospitals regarding the voluntary recall of ciprofloxacin 2 mg/mL IV bags.

Reactions Weekly, Vol. 1, Iss. 1306, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

In Canada, GlaxoSmithKline has advised that the concomitant use of Paxil [paroxetine] and Orap [pimozide] is contraindicated

Reactions Weekly, Vol. 1, Iss. 1062, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Health Canada has granted a notice of compliance for Bristol-Myers Squibb's dasatinib [Sprycel] for use in patients with chronic myeloid leukaemia

Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Estradiol/norethisterone has been approved by Health Canada

Inpharma, Vol. 1, Iss. 1644, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Health Canada has approved fludarabine [`Fludara'; Berlex Canada] in an additional indication

Inpharma, Vol. 1, Iss. 1317, 2001-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite